AAA - Abdominal Aortic Aneurysm
15
5
6
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 15 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (15)
Data Collection of the TUVA BX and iCover Stent Grafts Implanted During Branched Endovascular Aortic Repair (BEVAR)
Perioperative Hypotension and Survival After Elective AAA Repair
Nectero EAST System Retreatment Study
Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis
Targeted Abdominal CT in Conjunction With Lung Cancer Screening
Endurant CHevAr New Indication Trial: ENCHANT
JAGUAR Trial (Outside United States; OUS): ObJective Analysis to GaUge EVAR Outcomes Through Randomization
JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization
Retrospective Post-Market Clinical Follow-Up Study of GORE-TEX® Vascular Grafts and GORE® PROPATEN® Vascular Graft in Peripheral Artery Disease, Aortic Aneurysms, and Dialysis Access
Virtual Prehabilitation for Patients Undergoing Abdominal Aortic Aneurysm Repair
Prediction of Abdominal Aortic Aneurysm Shrinkage After Stent-placement With Artificial Intelligence
Automatic Abdominal Aortic Aneurysm Diameter Measurement
Sex-specific Differences in AAA Complexity
A Study of the Safety of Targeted AAA Screening
Cross-sectional Study of Prevalence Rate of Abdominal Aortic Aneurysm in OSAHS Patients From BTCH